Molecular prognostic markers in breast cancer

被引：2
|
作者：
Rajvir Dahiya
Guoren Deng
机构：
来源：
Breast Cancer Research and Treatment | 1998年 / 52卷
关键词：
BRCA-1 and BRCA-2; p53; erbB oncogenes; LOH; chromosomal aberrations; microsatellite instability; TGFα; multidrug resistance (MDR) gene;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Based on the scientific literature, there are several molecular markers which might be used for the prognosis of breast cancer. Possible molecular prognostic markers are: BRCA-1, BRCA-2, p53, erbB oncogenes, loss of heterozygosity (LOH), chromosomal aberrations, microsatellite instability, transforming growth factor alpha (TGFα), and the multiple drug resistance (MDR) gene. In this chapter, we discuss the possible role of these prognostic markers in breast cancer.
引用
收藏
页码：185 / 200
页数：15
相关论文
共 50 条
  • [41] IGF system components as prognostic markers in breast cancer
    Lee, AV
    Hilsenbeck, SG
    Yee, D
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 47 (03) : 295 - 302
  • [42] Is there any role for new prognostic markers in breast cancer?
    Barnadas, Agusti
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (03): : 161 - 162
  • [43] BIOCHEMICAL MARKERS AS PROGNOSTIC INDEXES IN BREAST-CANCER
    DUFFY, MJ
    [J]. CLINICAL CHEMISTRY, 1990, 36 (02) : 188 - 191
  • [44] Methylated genes as prognostic and predictive markers in breast cancer
    Martens, John W. M.
    [J]. TUMOR BIOLOGY, 2007, 28 : 6 - 6
  • [45] TMEM and Menacalc: New prognostic markers for breast cancer
    Rohan, Thomas E.
    Oktay, Maja H.
    Sparano, Joseph A.
    Jones, Joan G.
    Entenberg, David R.
    Condeelis, John S.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 129 - 129
  • [46] The prognostic value of apoptotic and proliferative markers in breast cancer
    Engels, Charla C.
    Ruberta, Francesca
    de Kruijf, Esther M.
    van Pelt, Gabi W.
    Smit, Vincent T. H. B. M.
    Liefers, Gerrit Jan
    Matsushima, Tomoko
    Shibayama, Masaki
    Ishihara, Hideki
    van de Velde, Cornelis J. H.
    Kuppen, Peter J. K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (02) : 323 - 339
  • [47] Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients
    Wachter, David L.
    Fasching, Peter A.
    Haeberle, Lothar
    Schulz-Wendtland, Ruediger
    Dimmler, Arno
    Koscheck, Thomas
    Renner, Stefan P.
    Lux, Michael P.
    Beckmann, Matthias W.
    Hartmann, Arndt
    Rauh, Claudia
    Schrauder, Michael G.
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 287 (02) : 337 - 344
  • [48] Prognostic value of proliferation markers expression in breast cancer
    Natalija Dedić Plavetić
    Jasminka Jakić-Razumović
    Ana Kulić
    Damir Vrbanec
    [J]. Medical Oncology, 2013, 30
  • [49] Assessment of prognostic markers in young women with breast cancer
    Breborowicz, E.
    Litwiniuk, M.
    Brzostek, J.
    Wysocki, P.
    [J]. BREAST, 2012, 21 : S12 - S12
  • [50] Methylated genes as prognostic and predictive markers in breast cancer
    Martens, John W. M.
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (08) : 517 - 517
12345